Ams spectral sensing technology enables optical measurement technology company ELDIM to achieve rapid and professional detection of COVID-19

Ams, the world's leading provider of high-performance sensor solutions, has provided ELDIM, a French provider of optical measurement technology and related software and hardware design, with the latest sensor technology to help develop a COVID-19 (SARS-CoV-2) point-of-care application detection solution that leverages molecular biology techniques to improve the quality of life. When used in a professional medical setting, results can be obtained in only about 40 minutes - previously, such tests typically took hours or days. The specially developed sensor system based on AMS 'AS7341L spectral sensor solution can read amplified RNA of viral particles using spectral resolution, further strengthening AMS' position in providing high-quality professional health diagnostics.

Optical measurement techniques use light to determine unit standards of measurement and other standards for high-precision research. A team of several companies and institutions, These include Loop Dee Science, a biotech startup focused on point-of-care testing; LRX Technologies, a designer of tiny interconnected optical sensors; ELDIM, a maker of industrial readers; and the virology department at CHU Caen University Hospital in Normandy. Provides scientific advice and clinical supervision) and has been actively researching the project for several months. These institutions are located in Normandy, France. Eventually, they successfully developed the LoopXplore COVID-19 analysis Kit and LoopX, a portable automated diagnostic professional tool.

Miniaturization of PCR tests in professional medical Settings

PCR (polymerase chain reaction) testing is the basis for most genetic tests performed today and is currently the most commonly used test for COVID-19 (SARS-CoV-2). However, the equipment used and the expertise required to interpret the data are highly specialized, can also be expensive, and can only be carried out in centralized laboratories. In contrast, the new test offered by ELDIM and its partners uses thermostatic amplification to detect the virus itself, eliminating the need for bulky equipment. The advantage of this approach is that patients can get an accurate test of their health status almost instantly, thus avoiding the spread of the virus.

Working together to improve COVID-19 health outcomes

"The combination of ELDIM's high-precision engineering and design capabilities with our partners' technical and clinical insights, coupled with AMS 'high-performance and highly sensitive spectral sensors, resulted in a miniature detection method that is faster and more flexible than PCR detection, while still having the same accuracy." Pascal Philippon, Senior Vice President of Sales and Marketing at AMS Europe, Middle East and Africa.

"ELDIM has always been committed to supporting startups in developing new projects in various sectors. During the implementation of this important project, we were responsible for overseeing the sensor and analytics components of the LoopX solution. Our proven experience in high-end, high-volume production processes and manufacturing capabilities will bring excellent detection accuracy and reliability to healthcare organizations and future users, "said Thierry Leroux, President and CEO of ELDIM.